Profit

Johnson & Johnson Says In Early Talks To Buy Drug Maker Actelion

 Share
EMAIL
PRINT
COMMENTS
Johnson & Johnson Says In Early Talks To Buy Drug Maker Actelion

Johnson & Johnson develops drugs and makes medical devices, among other products.(Representational image)


New York: Johnson & Johnson said on Friday that is in early talks to buy Swiss drug maker Actelion Pharmaceuticals.

Actelion Pharmaceuticals Ltd makes high blood pressure medicines that treat arteries in the lung and around the heart. Johnson & Johnson, of New Brunswick, New Jersey, develops drugs and manufactures medical devices and other consumer products.

Johnson & Johnson shares rose by $1.06 to $114.13 on Friday.

NDTV Beeps - your daily newsletter

................................ Advertisement ................................

................................ Advertisement ................................

................................ Advertisement ................................

Top